Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0806
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-17T06:22:35.088372Z
status: published
lens: g_space
sector: health
headline: Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma
dek: Immunotherapy resistance in lung adenocarcinoma (LUAD) remains a critical clinical challenge, and the mechanisms underlying resistance-associated intratumoral heterogeneity are poorly characterized. We performed single-cell RNA sequencing of LUAD patients receiving neoadjuvant immunotherapy (responders vs. non-responders), integrating inferCNV, GSVA, and differential expression analyses. Cluster-specific genes were validated across seven independent cohorts (TCGA-LUAD, GSE13213, GSE26939, GSE29016, GSE30219, GSE…
gain_title: A CoxBoost + survivalSVM prognostic model built from resistance-associated cluster genes achieved C-index 0.686 and stratified LUAD patients with HR 2.54-10.51, with low-risk patients showing greater immune infiltration and ARNTL2 knockdown suppressing proliferation and invasion in A549 and H1299 cells.
problem_title: (none)
trace_subject: (none)
gain_reading: A CoxBoost + survivalSVM prognostic model built from resistance-associated cluster genes achieved C-index 0.686 and stratified LUAD patients with HR 2.54-10.51, with low-risk patients showing greater immune infiltration and ARNTL2 knockdown suppressing proliferation and invasion in A549 and H1299 cells.
gain_evidence: CoxBoost combined with survivalSVM achieved optimal predictive performance (C-index = 0.686) | its knockdown suppressed proliferation and invasion in both LUAD cell lines (all p < 0.05)
problem_reading: (none)
problem_evidence: (none)
quick_read: By August 2026, researchers had used single-cell RNA sequencing of lung adenocarcinoma patients treated with neoadjuvant immunotherapy to map resistance-associated heterogeneity, identifying a malignant Cluster 2 enriched in non-responders with upregulated KRT17, S100A2, and CST6, and built a CoxBoost combined with survivalSVM prognostic model validated across seven independent cohorts.

The work matters because it links a machine-learning-derived risk score to immune infiltration and immunophenoscores and experimentally implicates ARNTL2 as a driver whose knockdown reduces proliferation and invasion, but it remains uncertain whether the C-index of 0.686 and cell-line findings will translate to prospective clinical utility or in vivo therapeutic efficacy.
limitation: 
tag: Evidence-backed gain
key_points: Single-cell RNA sequencing of LUAD neoadjuvant immunotherapy responders vs non-responders identified resistance-enriched malignant Cluster 2 with hyperproliferative and metabolic reprogramming. | Non-responders showed enrichment of epithelial cells, depletion of cytotoxic T/NK cells, and elevated copy number variation burden versus responders (p < 0.0001). | Cluster genes KRT17, S100A2, and CST6 showed tumor-specific overexpression, adverse prognostic value, and genomic amplification across seven cohorts including TCGA-LUAD. | ARNTL2 was an independent prognostic factor (HR: 2.07-4.64) correlated with risk score (r = 0.69) and validated as oncogenic driver in vitro.
rundown: Researchers performed single-cell RNA sequencing on LUAD patients receiving neoadjuvant immunotherapy, integrating inferCNV, GSVA, and differential expression to compare responders and non-responders, and validated cluster-specific genes across TCGA-LUAD and six GEO cohorts.

A multi-algorithm machine learning framework selected CoxBoost + survivalSVM as optimal, with immune characterization via TCIA scoring, seven infiltration algorithms, and ESTIMATE, and functional validation of ARNTL2 by CCK-8 and Transwell assays in A549 and H1299 cells.
sources:
- peer_reviewed | Translational Oncology | https://doi.org/10.1016/j.tranon.2026.102971 | 2026-08-15
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

0fa749e7563743313760f3a42ec8b9795d28ded19091ccbb4714bf5c205a93cd

previous

0000000000000000000000000000000000000000000000000000000000000000